Of the studies reporting an association between mutation in α2M and risk of Alzheimer's disease, one study has reported that there is a synergistic effect between polymorphisms in α2M and myeloperoxidase and an increased risk of Alzheimer's disease [36]. The gene discussed is MPO; the disease is early-onset autosomal dominant Alzheimer disease.